ÜBERLEBEN UND REZIDIV VON PROSTATAKREBS

Patent europeic · EP2121988 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2121988
Numer da la dumonda
EP08730593
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-02-2008
Publitgà
25-11-2009
Concedì
17-12-2014
Stritgà
28-02-2015
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/68 (2006.01)
Prioritad
US 891477 P 23.02.2007
Dumonda PCT
PCT/US2008/054820 25.02.2008
Publicaziun PCT
WO2008/103971 28.08.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2015

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2015

  2. 17-12-2014

    Concedì

    Published in Swissreg on 17.12.2014

Partidas

Possessur

Biotheranostics, Inc.

bioTheranostics, Inc.

9640 Towne Centre Drive, Suite 200, San Diego, CA 92121, US

General Hospital Corporation

55 Fruit Street, Boston, MA 02114, US

Inventur

MA, Xiao-Jun

San Diego, CA 92130, US

WU, Chin-Lee

Newton, MA 02459, US

ERLANDER, Mark, G.

Carlsbad, CA 92011, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.